(VIANEWS) – Franklin Universal Trust (FT), Bristol (BMY), PCB Bancorp (PCB) have the highest dividend yield stocks on this list.
Financial Asset | Forward Dividend Yield | Updated (EST) |
---|---|---|
Franklin Universal Trust (FT) | 7.47% | 2024-05-10 18:07:10 |
Bristol (BMY) | 5.82% | 2024-05-26 03:14:56 |
PCB Bancorp (PCB) | 4.79% | 2024-05-24 19:43:06 |
Xcel Energy (XEL) | 4.08% | 2024-05-26 03:14:12 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Franklin Universal Trust (FT) – Dividend Yield: 7.47%
Franklin Universal Trust’s last close was $6.83, 3.26% below its 52-week high of $7.06. Intraday change was -0.22%.
Franklin Universal Trust is a closed-ended balanced mutual fund launched by Franklin Resources, Inc. The fund is managed by Franklin Advisers, Inc. It invests in the public equity and fixed income markets of the United States. The fund invests in companies operating in utility sector. It employs fundamental analysis to invest in a diversified portfolio of corporate bonds and dividend paying utility stocks. The fund benchmarks the equity component of its balanced portfolio against the S&P 500 Electric Utilities Index and the fixed component against the Credit Suisse High Yield. Franklin Universal Trust was formed on September 23, 1988 and is domiciled in the United States.
Earnings Per Share
As for profitability, Franklin Universal Trust has a trailing twelve months EPS of $0.44.
PE Ratio
Franklin Universal Trust has a trailing twelve months price to earnings ratio of 15.48. Meaning, the purchaser of the share is investing $15.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.91%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14%, now sitting on 17.07M for the twelve trailing months.
Moving Average
Franklin Universal Trust’s value is higher than its 50-day moving average of $6.56 and higher than its 200-day moving average of $6.55.
Volume
Today’s last reported volume for Franklin Universal Trust is 36893 which is 39.6% below its average volume of 61085.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 16, 2024, the estimated forward annual dividend rate is 0.51 and the estimated forward annual dividend yield is 7.47%.
More news about Franklin Universal Trust.
2. Bristol (BMY) – Dividend Yield: 5.82%
Bristol’s last close was $41.24, 37.95% under its 52-week high of $66.46. Intraday change was -1.71%.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $3.86.
PE Ratio
Bristol has a trailing twelve months price to earnings ratio of 12.51. Meaning, the purchaser of the share is investing $12.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.33%.
Volume
Today’s last reported volume for Bristol is 10036300 which is 37.75% below its average volume of 16123300.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Bristol’s stock is considered to be overbought (>=80).
More news about Bristol.
3. PCB Bancorp (PCB) – Dividend Yield: 4.79%
PCB Bancorp’s last close was $15.18, 20.27% below its 52-week high of $19.04. Intraday change was 0.93%.
PCB Bancorp operates as the bank holding company for PCB Bank that provides various banking products and services to small to medium-sized businesses, individuals, and professionals in Southern California. The company offers demand, savings, money market, and time deposits, as well as certificates of deposit; and trade finance, remote deposit capture, courier deposit services, positive pay services, zero balance accounts, and sweep accounts. It also provides real estate loans, including commercial and residential, Small Business Administration (SBA) property, and construction loans; commercial and industrial loans, such as commercial term and lines of credit, SBA commercial term, and SBA Paycheck Protection Program loans; and other consumer loans comprising automobile secured loans and personal loans. In addition, the company offers access to account balances, online transfers, and online bill payment and electronic delivery of customer statements; and mobile banking solutions that include remote check deposit and mobile bill pay. Further, it provides automated teller machines; and banking by telephone, mail, personal appointment, debit cards, direct deposit, and cashier's checks, as well as treasury management, wire transfer, and automated clearing house services. The company operates through a network of full-service branches in Los Angeles and Orange counties, California; Carrollton and Dallas, Texas; and Englewood Cliffs and Palisade Park, New Jersey, and Bayside, New York. It also operates loan production offices in Los Angeles and Orange Counties, California; Annandale, Virginia; Atlanta, Georgia; Bellevue, Washington; Aurora, Colorado; and Carrollton, Texas. The company was formerly known as Pacific City Financial Corporation and changed its name to PCB Bancorp in July 2019. PCB Bancorp was founded in 2003 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, PCB Bancorp has a trailing twelve months EPS of $1.75.
PE Ratio
PCB Bancorp has a trailing twelve months price to earnings ratio of 8.67. Meaning, the purchaser of the share is investing $8.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.31%.
More news about PCB Bancorp.
4. Xcel Energy (XEL) – Dividend Yield: 4.08%
Xcel Energy’s last close was $53.72, 18.13% below its 52-week high of $65.62. Intraday change was -0.6%.
Xcel Energy Inc., through its subsidiaries, engages in the generation, purchasing, transmission, distribution, and sale of electricity. It operates through Regulated Electric Utility, Regulated Natural Gas Utility, and All Other segments. The company generates electricity through wind, nuclear, hydroelectric, biomass, and solar energy sources, as well as coal, natural gas, oil, wood, and refuse-derived fuels. It also purchases, transports, distributes, and sells natural gas to retail customers, as well as transports customer-owned natural gas. In addition, the company develops and leases natural gas pipelines, and storage and compression facilities; and invests in rental housing projects and nonregulated assets, as well as procures equipment for the construction of renewable generation facilities. It serves residential, commercial, and industrial customers in the portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. The company was incorporated in 1909 and is headquartered in Minneapolis, Minnesota.
Earnings Per Share
As for profitability, Xcel Energy has a trailing twelve months EPS of $3.21.
PE Ratio
Xcel Energy has a trailing twelve months price to earnings ratio of 16.56. Meaning, the purchaser of the share is investing $16.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.62%.
Sales Growth
Xcel Energy’s sales growth for the current quarter is 7.3%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2024, the estimated forward annual dividend rate is 2.19 and the estimated forward annual dividend yield is 4.08%.
Volatility
Xcel Energy’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.01%, a positive 0.02%, and a positive 1.29%.
Xcel Energy’s highest amplitude of average volatility was 1.46% (last week), 0.75% (last month), and 1.29% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Xcel Energy’s stock is considered to be overbought (>=80).
More news about Xcel Energy.